Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Alexis Nolin-Lapalme"'
Autor:
Marion Tonneau, Alexis Nolin-Lapalme, Suzanne Kazandjian, Edouard Auclin, Justin Panasci, Myriam Benlaifaoui, Mayra Ponce, Afnan Al-Saleh, Wiam Belkaid, Sabrine Naimi, Catalin Mihalcioiu, Ian Watson, Mickael Bouin, Wilson Miller, Marie Hudson, Matthew K. Wong, Rossanna C. Pezo, Simon Turcotte, Karl Bélanger, Rahima Jamal, Paul Oster, Dominique Velin, Corentin Richard, Meriem Messaoudene, Arielle Elkrief, Bertrand Routy
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
The microbiome is now regarded as one of the hallmarks of cancer and several strategies to modify the gut microbiota to improve immune checkpoint inhibitor (ICI) activity are being evaluated in clinical trials. Preliminary data regarding the upper ga
Externí odkaz:
https://doaj.org/article/adb7b6925dfe48898a2dcd6d9e30f8ad
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Supplementary Figure from A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti–PD-1 Resistance through Effects on the Gut Microbiota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d53878c67784949fac07f86d3d9c437
https://doi.org/10.1158/2159-8290.22541432.v1
https://doi.org/10.1158/2159-8290.22541432.v1
Autor:
Bertrand Routy, Bastien Castagner, André Marette, Arielle Elkrief, Guido Kroemer, Sylvere Durand, Emmanuelle Le Chatelier, Oscar Gitton-Quent, Florian Plaza Oñate, Geneviève Pilon, Emilia Liana Falcone, Yves V. Brun, David T. Kysela, Sandy Chevrier, Romain Boidot, François Ghiringhelli, Didier Raoult, Paul Oster, Dominique Velin, Lharbi Dridi, Yves Fradet, Stephane Isnard, Wiam Belkaid, Julie Malo, Florent Cauchois, Alexis Nolin-Lapalme, Myriam Benlaifaoui, Khoudia Diop, Mayra Ponce, Corentin Richard, Reilly Pidgeon, Meriem Messaoudene
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774cbed002cf5fe66d2f547187bce8cc
https://doi.org/10.1158/2159-8290.c.6549638
https://doi.org/10.1158/2159-8290.c.6549638
Autor:
Ana Rio-Machin, Findlay Bewicke-Copley, Jiexin Zheng, Pedro Casado Izquierdo, Juho J. Miettinen, Naeem Khan, Jonas Demeulemeester, Szilvia Krizsán, Christopher Middleton, Sam Benkwitz-Bedford, Joseph Saad, Amaia Vilas-Zornoza, Teresa Ezponda, William Grey, Vincent-Philippe Lavallée, Alexis Nolin-Lapalme, Farideh Miraki-Moud, Janet Matthews, Marianne Grantham, Ryan J Colm, Jonathan Bond, Doriana Di Bella, Krister Wennerberg, Alun Parsons, Andy G.X. Zeng, Hannah Armes, Karina Close, Fadimana Kaya, Kevin Rouault-Pierre, John G. Gribben, Felipe Prosper, James Cavenagh, John E. Dick, Sylvie D Freeman, Peter Van Loo, Csaba Bödör, Guy Sauvageau, Kimmo Porkka, Caroline A. Heckman, Jun Wang, Jean-Baptiste Cazier, David Taussig, Dominique Bonnet, Pedro Cutillas, Jude Fitzgibbon
Publikováno v:
Blood. 140:1030-1032
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18d0ccd83c0b4c420b0fe824cf8a8dbc
https://doi.org/10.1182/blood-2022-159069
https://doi.org/10.1182/blood-2022-159069
Autor:
Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa, Yusuke Okuma, Shohei Nakamura, Danielle Moreau-Amaru, Taichi Tamura, Yukio Hosomi, Haruko Takeyama, Corentin Richard, Masahito Hosokawa, Bertrand Routy
Publikováno v:
Cancers; Volume 14; Issue 21; Pages: 5405
Cancer cachexia exerts a negative clinical influence on patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI). The prognostic impact of body weight change during ICI treatment remains unknown. The g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6cc02395c056d10663d8c0a0eec92bd
Autor:
Meriem Messaoudene, Reilly Pidgeon, Corentin Richard, Mayra Ponce, Khoudia Diop, Myriam Benlaifaoui, Alexis Nolin-Lapalme, Florent Cauchois, Julie Malo, Wiam Belkaid, Stephane Isnard, Yves Fradet, Lharbi Dridi, Dominique Velin, Paul Oster, Didier Raoult, François Ghiringhelli, Romain Boidot, Sandy Chevrier, David T. Kysela, Yves V. Brun, Emilia Liana Falcone, Geneviève Pilon, Florian Plaza Oñate, Oscar Gitton-Quent, Emmanuelle Le Chatelier, Sylvere Durand, Guido Kroemer, Arielle Elkrief, André Marette, Bastien Castagner, Bertrand Routy
Publikováno v:
Cancer Discovery
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Cancer Discovery, 2022, 12 (4), pp.1070-1087. ⟨10.1158/2159-8290.CD-21-0808⟩
Several approaches to manipulate the gut microbiome for improving the activity of cancer immune-checkpoint inhibitors (ICI) are currently under evaluation. Here, we show that oral supplementation with the polyphenol-rich berry camu-camu (CC; Myrciari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18a105952b8704bcf86e6485365a5ab9
https://doi.org/10.1158/2159-8290.CD-21-0808
https://doi.org/10.1158/2159-8290.CD-21-0808
Autor:
Khoudia Diop, Benlaïfaoui Myriam, Wiam Belkaïd, Alexis Nolin-Lapalme, Julie Malo, Marion Tonneau, Ponce Mayra, Afnan Al-Saleh, Catalin Mihalcioiu, Ian Watson, Arielle Elkrief, Karla Lee, Meriem Messaoudene, Bertrand Routy, Corentin Richard
Publikováno v:
Cancer Research. 82:3524-3524
The accelerating use of combined immune checkpoint inhibitors (ICI; anti-PD-1 plus anti-CTLA-4 antibodies) enhanced therapeutic responses in various cancers while significantly increasing immune-related adverse events (irAE). The mechanism involved i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96952284179e51d337d9f61db4c5bb08
https://doi.org/10.1158/1538-7445.am2022-3524
https://doi.org/10.1158/1538-7445.am2022-3524
Autor:
Marion Tonneau, Corentin Richard, Alexis Nolin-Lapalme, Edouard Auclin, Myriam Benlaifaoui, Mayra Ponce, Afnan Al-Saleh, Normand Blais, Marie Florescu, Mustapha Tehfe, Julie Malo, Meriem Messaoudene, Yusuke Okuma, Taiki Hakozaki, Bertrand Routy
Publikováno v:
Journal of Clinical Oncology. 40:9036-9036
9036 Background: Despite immune-checkpoint inhibitors (ICI) achieving high response rates in patients (pts) with advanced non-small cell lung cancer (NSCLC), immune-related adverse events (irAE) remain an important therapeutic hurdle. The gut microbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc022f3af3c07a7e6d0abe0b312a5208
https://doi.org/10.1200/jco.2022.40.16_suppl.9036
https://doi.org/10.1200/jco.2022.40.16_suppl.9036
Autor:
Edouard Auclin, Alexis Nolin-Lapalme, Corentin Richard, Julie Malo, Marion Tonneau, Myriam Benlaifaoui, Mayra Ponce, Meriem Messaoudene, Yusuke Okuma, Taiki Hakozaki, Bertrand Routy
Publikováno v:
Journal of Clinical Oncology. 40:9050-9050
9050 Background: Host-related inflammatory biomarkers and gut microbiome are two major prognostic factors for non-small cell lung cancer (NSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI). In this study, we aimed to assess an asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8477dbdc33f8907400d9d8dad8832767
https://doi.org/10.1200/jco.2022.40.16_suppl.9050
https://doi.org/10.1200/jco.2022.40.16_suppl.9050
Autor:
A. Laparra, Malik Berhoune, Christophe Massard, Cécile Cauquil, Stéphane Champiat, Benjamin Besse, Alexis Nolin-Lapalme, Caroline Robert, Christine Mateus, Charles Naltet, Frédéric Troalen, Olivier Lambotte, Stéphane Ederhy, Capucine Baldini, Aurélien Marabelle, Patricia Martin-Romano, Samia Hajem, Antoine Hollebecque, Jean-Marie Michot, P. Vuagnat
Publikováno v:
European journal of cancer (Oxford, England : 1990). 157
Aim Despite unprecedented results of anti-programmed death protein (ligand) 1 (PD-(L)1) immune checkpoint inhibitor in the oncology's armamentarium, immune-related adverse events (irAEs) represent a therapeutic hurdle. Currently, there is no consensu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1483b4b99b2d5a1d5425c49704be64
https://pubmed.ncbi.nlm.nih.gov/34571335
https://pubmed.ncbi.nlm.nih.gov/34571335